Symptomatic infection tied to three times greater risk for developing new or worsening overactive bladder symptoms<\/p>\n<\/h3>\n
<\/b><\/p>\n
<\/b><\/p>\n
MONDAY, Nov. 7, 2022 (HealthDay News) — COVID-19 infection is associated with an increased risk for developing new or worsening overactive bladder symptoms, according to a study published in the December issue of European Urology Open Science<\/em>.<\/p>\n Ly Hoang Roberts, from the Oakland University William Beaumont School of Medicine in Royal Oak, Michigan, and colleagues assessed the incidence of COVID-19-associated cystitis (CAC) and its association with severe acute respiratory syndrome coronavirus-2 antibody levels. The analysis included 1,895 health care employees participating in the BLAST COVID study group.<\/p>\n The researchers found that 27.4 percent of those with positive serology only (asymptomatic COVID-19) and 37.8 percent of those with polymerase chain reaction positivity (symptomatic COVID-19) had an increase of 1 or more point on the International Consultation on Incontinence Questionnaire-overactive bladder since baseline, versus 15.8 percent of uninfected patients (odds ratios, 2.0 and 3.2, respectively). <\/p>\n “The exact pathophysiology of CAC is yet to be discovered, although others have hypothesized that the increase in systemic inflammation on COVID-19 infection can lead to bladder inflammation and thus bothersome urinary symptoms,” the authors write.<\/p>\n One author disclosed financial ties to the biopharmaceutical industry.<\/p>\n